GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Charming Medical MCTA · USD

Consumer Discretionary · US listing · 🇺🇸 United States

Compare

29.35

—

Close of 28 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$4.8m

FY2023FY2026

Net income

−$22,648

FY2023FY2026

Free cash flow

−$1.6m

FY2023FY2026

Shareholders' equity

$5.2m

FY2023FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023
Revenue$4.8m$6.2m$6.0m$3.5m
Gross profit$3.0m$4.2m$3.9m$1.5m
Operating income$128,873$1.4m$1.0m−$521,336
Net income−$22,648$1.2m$777,811−$305,117
Diluted earnings per share-0.000.070.05-0.02

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023
Total assets$9.9m$5.4m$4.9m$6.4m
Cash and short-term investments—$2.8m$2.1m$1.9m
Total liabilities$4.7m$5.3m$6.0m$7.7m
Debt—$1.2m$961,379$1.8m
Shareholders' equity$5.2m$49,243−$1.1m−$1.2m
Shares outstanding17m17m17m17m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023
Cash from operations−$1.2m$425,888$295,429$2.4m
Capital spending−$339,560−$287,527−$210,598−$606,194
Free cash flow−$1.6m$138,361$84,831$1.8m

Latest quarters

By quarter end

Mar 2025Sept 2024Mar 2024
Revenue$6.2m$3.0m$6.0m
Gross profit$6.2m$3.0m$6.0m
Operating income$1.4m$554,800$1.0m
Net income$1.2m$468,800$777,800
Diluted earnings per share0.070.030.05
Total assets$5.4m$5.4m$4.9m
Cash and short-term investments$2.8m$2.7m$2.1m
Debt$802,606$895,101$813,129
Shareholders' equity$49,243−$681,055−$1.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.4%——
Net income-58.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin65.2%61.2%——

Valuation history

At each fiscal year end

FY2026FY2025
Price to earnings-22265.1414.7
Price to sales108.383.0

Share price return

Finished calendar years

2025
Return319%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.